Peiyuan Wang

This inventor holds 49 USPTO granted patents and 11 published patent applications, plus 16 CIPO patents and 26 EPO patents, primarily in Pharmaceutical Innovations. Top assignees: Gilead Sciences, Inc., Gilead Pharmasset LLC, Pharmasset, Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peiyuan Wang. Retrieved from https://idiyas.com/inventor/peiyuan-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 49 (Patent Applications = 11)

% Patents Active = 98.0

CIPO Patents = 16 (Patent Applications = 8)

EPO Patents = 26 (Patent Applications = 26)

Average Co-Inventor Count = 6.1

ph-index = 19

Forward Citations = 1,253(Granted Patents)

Location History:

Lilburn, GA (US) (2012)
Glen Rock, NJ (US) (2009 - 2015)
Foster City, CA (US) (2014 - 2015)
Totowa, NJ (US) (2013 - 2017)
San Mateo, CA (US) (2017 - 2024)

Company Filing History:

24 out of 946

Gilead Sciences, Inc.

patents

21 out of 81

Gilead Pharmasset LLC

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

PD-1 Inhibitors

PD-L1 Inhibitors

Nucleoside Phosphoramidates

Phospholipid Compounds

Antiviral Compounds

LPA Receptor Antagonists

Tank-Binding Kinase Inhibitors

Triazole Carbamate

Indolinyl Compounds

Prodrugs

Pyridyl Sulfonamides

Ribofuranosyl Pyrimidines

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590062 - PD-1/PD-L1 inhibitors (2026-03-31),

2. 12522582 - ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF (2026-01-13),

3. 12473314 - Phospholipid compounds and uses thereof (2025-11-18),

4. 12338233 - PD-1/Pd-L1 inhibitors (2025-06-24),

5. 12269812 - PD-1/PD-L1 inhibitors (2025-04-08),

6. 12208110 - Phospholipid compounds and uses thereof (2025-01-28),

7. 12121529 - Nucleoside phosphoramidate prodrugs (2024-10-22),

8. 12030904 - Phospholipid compounds and uses thereof (2024-07-09),

9. 11999717 - Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof (2024-06-04),

10. 11963967 - Phospholipid compounds and uses thereof (2024-04-23),

11. 11773122 - Phospholipid compounds and uses thereof (2023-10-03),

12. 11642361 - Nucleoside phosphoramidate prodrugs (2023-05-09),

13. 11584738 - LPA receptor antagonists and uses thereof (2023-02-21),

14. 11555029 - PD-1/PD-L1 inhibitors (2023-01-17),

15. 11548871 - Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof (2023-01-10),

Title: The Innovative Mind of Peiyuan Wang

Introduction: Peiyuan Wang is a visionary inventor based in San Mateo, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Peiyuan Wang holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a background in computer science and engineering, Peiyuan Wang has had a successful career working with leading tech companies, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Throughout his career, Peiyuan Wang has collaborated with top researchers, engineers, and developers to bring his innovative ideas to life, leading to the creation of cutting-edge technologies that have had a lasting impact.

Conclusion: Peiyuan Wang's relentless pursuit of innovation and his passion for creating solutions to complex technological challenges make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.